Prostate Cancer - Results from #100

Time without PSA recurrence after radical prostatectomy as a predictor of future biochemical recurrence, metastatic disease and prostate cancer death: a prospective Scandinavian cohort study. January 5, 2023

Avelumab Plus Talazoparib in Patients With Advanced Solid Tumors: The JAVELIN PARP Medley Nonrandomized Controlled Trial. January 5, 2023

A Low PSA Predicts a Worse Outcome in High but Not in Low/Intermediate Grade Prostate Cancer January 4, 2023

Five-year patient reported outcomes in NRG Oncology RTOG 0938, evaluating two ultrahypofractionated regimens for prostate cancer. January 4, 2023

The function of Prostate Health Index in detecting clinically significant prostate cancer in the PI-RADS 3 population: a multicenter prospective study. January 4, 2023

Radiorecurrent prostate cancer: advantages and disadvantages of salvage radical prostatectomy. January 4, 2023

Utilization of genetic testing in men with advanced prostate cancer. January 4, 2023

The Prevalence of Low-Value Prostate Cancer Screening in Primary Care Clinics: A Study Using the National Ambulatory Medical Care Survey. January 4, 2023

A prospective, multicenter head-to-head comparative study in patients with primary high-risk prostate cancer investigating the bone lesion detection of conventional imaging and 18F-PSMA-PET/CT. January 3, 2023

Accuracy of PET-choline in nodal staging of localized very high-risk prostate cancer. January 3, 2023

Deep learning and radiomics framework for PSMA-RADS classification of prostate cancer on PSMA PET. January 3, 2023

Body composition and mortality in men receiving prostate radiotherapy: A pooled analysis of NRG/RTOG 9406 and NRG/RTOG 0126. January 3, 2023

The presence of lymph node metastases and time to castration resistance predict the therapeutic effect of enzalutamide for castration-resistant prostate cancer. January 3, 2023

Mainstream germline genetic testing in men with metastatic prostate cancer: design and protocol for a multicenter observational study. January 2, 2023

MyProstateScore in men considering repeat biopsy: validation of a simple testing approach. January 2, 2023

Prostate-specific Antigen Kinetics During Androgen-deprivation Therapy Predict Response to Enzalutamide in Metastatic Castration-resistant Prostate Cancer. January 2, 2023

Enzalutamide or Abiraterone Acetate With Prednisone in the Treatment of Metastatic Castration-resistant Prostate Cancer in Real-life Clinical Practice: A Long-term Single Institution Experience. January 2, 2023

Integrin Expression in Localized Prostate Cancer: A TCGA and MSKCC Cohort-based Exploratory In Silico Analysis. January 2, 2023

Medium-term oncological outcomes of intermediate-risk prostate cancer treated with HIFU or cryotherapy. A single center 10-year experience. December 30, 2022

A single-operator experience using EchoLaser SoracteLiteTM for focal laser ablation of prostate cancer: One more arrow in the quiver for the conservative management of the disease. December 30, 2022

Page 6 of 1275

email news signup